Description

Emerging Clinical Diagnostics Laboratory – Built for Scale | $4–$5M Revenue Growth Potential

This is a rare opportunity to acquire a fully credentialed clinical medical laboratory in its early growth stage, strategically positioned to scale to $4–$5 million in annual revenue within the next 24 months under focused business development and payer expansion.

Importantly, this is not a startup concept — it is an operational, credentialed lab platform. The infrastructure, licensing, equipment, and compliance foundation are already in place. Replicating this build-out from scratch would conservatively exceed $4 million in capital investment, making this a true replacement-cost opportunity with substantial upside.

Business Overview

This clinical laboratory provides a wide range of diagnostic testing services used by healthcare providers to diagnose, monitor, and screen for health conditions. The lab is:

• Registered with an active NPI (National Provider Identifier)

• Operating under CLIA certification

• Approved to perform regulated clinical laboratory testing

The platform is structured for expansion, not stabilization — presenting a growth-oriented acquisition opportunity.

Services & Capabilities

The lab currently offers a broad testing menu, including:

• Genetic and molecular diagnostics

• Routine clinical testing

• Clinical toxicology

• Allergy testing

• COVID-19 testing

Regulatory listings allow testing across multiple disciplines, including:

• Bacteriology

• Clinical chemistry

• Immunology (serology)

• Endocrinology

• Hematology

• Toxicology

• Urinalysis

• Virology

This diversified testing capability supports scalability across multiple provider verticals.

Clinical Credentials

The laboratory team includes:

• Board-certified pathologists

• Ph.D.-level professionals with credentials in molecular diagnostics

• Qualified clinical laboratory personnel

The lab emphasizes competitive turnaround times and flexible provider ordering/reporting systems, creating a scalable provider-facing platform.

Location & Market

Located in Central New Jersey, servicing healthcare providers throughout New York and New Jersey — two of the most regulated and high-value healthcare markets in the country.

Growth Opportunity- ASSET SALE

This lab is in its infancy operationally but fully built structurally. Key growth drivers include:

• Expansion of provider network

• Increased specimen volume

• Strategic payer contracting

• Sales force deployment

• Targeted specialty testing expansion

With proper capitalization and business development, the platform is positioned for significant near-term revenue growth.

Ideal Buyer

• Strategic laboratory operators

• Healthcare investors

• Private equity groups

• Physician groups seeking vertical integration

• Healthcare consolidators

Confidential offering. Financials, payer mix, equipment schedules, and regulatory documentation available upon NDA.